Nigerian government enters joint venture with May & Baker for local production of vaccines
The Managing Director of May & Baker Nigeria Plc, Pharm Nnamdi Okafor, has announced that the company is taking steps to ensure the quick commencement of local production of vaccines.
Speaking at the inauguration of the board of Biovaccines Nigeria Limited which is the vaccine production arm of the company that has gotten the nod of the Nigerian government, the company is already preparing the ground for production to commence in 2 years.
Biovaccines Nigeria Limited is a joint venture of the Nigerian government and May & Baker Nigeria. While May & Baker holds the majority 51% stake, the Federal Government of Nigeria holds the remaining 41 per cent.
The management board of Biovaccines Nigeria Limited was inaugurated on Wednesday by Minister of Health, Prof. Isaac Adewole. Members are Prof Oyewole Tomori, a renown virologist, Dr. Faisal Shuaib, Executive Director and Chief Executive Officer, National Primary Health Care Development Agency, Pharm. M. Lawal, Director, Food & Drugs, Federal Ministry of Health, Pharm Nnamdi Okafor, Managing Director, May & Baker Nigeria Plc, Dr. Edugie Abebe, a former Permanent Secretary and Director of May & Baker Nigeria and Mr. Ayodeji Aboderin, Director of Finance , May & Baker Nigeria.
The Managing Director of Biovaccines Nigeria Limited, who will be announced soon, is also expected to join the board.